Inozyme Pharma CEO Axel Bolte's 2022 pay slips 16% to $2.2M
Inozyme Pharma reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Inozyme Pharma reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at Inozyme Pharma received on average a compensation package of $1.5M, a 21% decrease compared to previous year.
Average pay of disclosed executives at Inozyme Pharma
Axel Bolte, Chief Executive Officer, received $2.2M in total, which decreased by 16% compared to 2021. 53% of Bolte's compensation, or $1.2M, was in option awards. Bolte also received $306K in non-equity incentive plan, $560K in salary, as well as $169K in other compensation.
Sanjay S. Subramanian, Chief Financial Officer, received a compensation package of $1.2M. 42% of the compensation package, or $522K, was in option awards.
Henric Bjarke, Chief Operating Officer, earned $959K in 2022, a 29% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2023.